Activation and allosteric modulation of a muscarinic acetylcholine receptor. 2013

Andrew C Kruse, and Aaron M Ring, and Aashish Manglik, and Jianxin Hu, and Kelly Hu, and Katrin Eitel, and Harald Hübner, and Els Pardon, and Celine Valant, and Patrick M Sexton, and Arthur Christopoulos, and Christian C Felder, and Peter Gmeiner, and Jan Steyaert, and William I Weis, and K Christopher Garcia, and Jürgen Wess, and Brian K Kobilka
1] Department of Molecular and Cellular Physiology, Stanford University School of Medicine, 279 Campus Drive, Stanford, California 94305, USA [2].

Despite recent advances in crystallography and the availability of G-protein-coupled receptor (GPCR) structures, little is known about the mechanism of their activation process, as only the β2 adrenergic receptor (β2AR) and rhodopsin have been crystallized in fully active conformations. Here we report the structure of an agonist-bound, active state of the human M2 muscarinic acetylcholine receptor stabilized by a G-protein mimetic camelid antibody fragment isolated by conformational selection using yeast surface display. In addition to the expected changes in the intracellular surface, the structure reveals larger conformational changes in the extracellular region and orthosteric binding site than observed in the active states of the β2AR and rhodopsin. We also report the structure of the M2 receptor simultaneously bound to the orthosteric agonist iperoxo and the positive allosteric modulator LY2119620. This structure reveals that LY2119620 recognizes a largely pre-formed binding site in the extracellular vestibule of the iperoxo-bound receptor, inducing a slight contraction of this outer binding pocket. These structures offer important insights into the activation mechanism and allosteric modulation of muscarinic receptors.

UI MeSH Term Description Entries
D007555 Isoxazoles Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions. Isoxazole
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011976 Receptors, Muscarinic One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology. Muscarinic Acetylcholine Receptors,Muscarinic Receptors,Muscarinic Acetylcholine Receptor,Muscarinic Receptor,Acetylcholine Receptor, Muscarinic,Acetylcholine Receptors, Muscarinic,Receptor, Muscarinic,Receptor, Muscarinic Acetylcholine,Receptors, Muscarinic Acetylcholine
D003593 Cytoplasm The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Protoplasm,Cytoplasms,Protoplasms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000494 Allosteric Regulation The modification of the reactivity of ENZYMES by the binding of effectors to sites (ALLOSTERIC SITES) on the enzymes other than the substrate BINDING SITES. Regulation, Allosteric,Allosteric Regulations,Regulations, Allosteric
D000644 Quaternary Ammonium Compounds Derivatives of ammonium compounds, NH4+ Y-, in which all four of the hydrogens bonded to nitrogen have been replaced with hydrocarbyl groups. These are distinguished from IMINES which are RN Quaternary Ammonium Compound,Ammonium Compound, Quaternary,Ammonium Compounds, Quaternary,Compound, Quaternary Ammonium
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D017434 Protein Structure, Tertiary The level of protein structure in which combinations of secondary protein structures (ALPHA HELICES; BETA SHEETS; loop regions, and AMINO ACID MOTIFS) pack together to form folded shapes. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Tertiary Protein Structure,Protein Structures, Tertiary,Tertiary Protein Structures

Related Publications

Andrew C Kruse, and Aaron M Ring, and Aashish Manglik, and Jianxin Hu, and Kelly Hu, and Katrin Eitel, and Harald Hübner, and Els Pardon, and Celine Valant, and Patrick M Sexton, and Arthur Christopoulos, and Christian C Felder, and Peter Gmeiner, and Jan Steyaert, and William I Weis, and K Christopher Garcia, and Jürgen Wess, and Brian K Kobilka
January 2023, Nature communications,
Andrew C Kruse, and Aaron M Ring, and Aashish Manglik, and Jianxin Hu, and Kelly Hu, and Katrin Eitel, and Harald Hübner, and Els Pardon, and Celine Valant, and Patrick M Sexton, and Arthur Christopoulos, and Christian C Felder, and Peter Gmeiner, and Jan Steyaert, and William I Weis, and K Christopher Garcia, and Jürgen Wess, and Brian K Kobilka
March 2019, ACS chemical neuroscience,
Andrew C Kruse, and Aaron M Ring, and Aashish Manglik, and Jianxin Hu, and Kelly Hu, and Katrin Eitel, and Harald Hübner, and Els Pardon, and Celine Valant, and Patrick M Sexton, and Arthur Christopoulos, and Christian C Felder, and Peter Gmeiner, and Jan Steyaert, and William I Weis, and K Christopher Garcia, and Jürgen Wess, and Brian K Kobilka
August 2010, Pharmaceuticals (Basel, Switzerland),
Andrew C Kruse, and Aaron M Ring, and Aashish Manglik, and Jianxin Hu, and Kelly Hu, and Katrin Eitel, and Harald Hübner, and Els Pardon, and Celine Valant, and Patrick M Sexton, and Arthur Christopoulos, and Christian C Felder, and Peter Gmeiner, and Jan Steyaert, and William I Weis, and K Christopher Garcia, and Jürgen Wess, and Brian K Kobilka
June 1995, Trends in pharmacological sciences,
Andrew C Kruse, and Aaron M Ring, and Aashish Manglik, and Jianxin Hu, and Kelly Hu, and Katrin Eitel, and Harald Hübner, and Els Pardon, and Celine Valant, and Patrick M Sexton, and Arthur Christopoulos, and Christian C Felder, and Peter Gmeiner, and Jan Steyaert, and William I Weis, and K Christopher Garcia, and Jürgen Wess, and Brian K Kobilka
September 2007, Current neuropharmacology,
Andrew C Kruse, and Aaron M Ring, and Aashish Manglik, and Jianxin Hu, and Kelly Hu, and Katrin Eitel, and Harald Hübner, and Els Pardon, and Celine Valant, and Patrick M Sexton, and Arthur Christopoulos, and Christian C Felder, and Peter Gmeiner, and Jan Steyaert, and William I Weis, and K Christopher Garcia, and Jürgen Wess, and Brian K Kobilka
May 2014, The Journal of biological chemistry,
Andrew C Kruse, and Aaron M Ring, and Aashish Manglik, and Jianxin Hu, and Kelly Hu, and Katrin Eitel, and Harald Hübner, and Els Pardon, and Celine Valant, and Patrick M Sexton, and Arthur Christopoulos, and Christian C Felder, and Peter Gmeiner, and Jan Steyaert, and William I Weis, and K Christopher Garcia, and Jürgen Wess, and Brian K Kobilka
February 2014, The Journal of biological chemistry,
Andrew C Kruse, and Aaron M Ring, and Aashish Manglik, and Jianxin Hu, and Kelly Hu, and Katrin Eitel, and Harald Hübner, and Els Pardon, and Celine Valant, and Patrick M Sexton, and Arthur Christopoulos, and Christian C Felder, and Peter Gmeiner, and Jan Steyaert, and William I Weis, and K Christopher Garcia, and Jürgen Wess, and Brian K Kobilka
July 1991, Biochemical pharmacology,
Andrew C Kruse, and Aaron M Ring, and Aashish Manglik, and Jianxin Hu, and Kelly Hu, and Katrin Eitel, and Harald Hübner, and Els Pardon, and Celine Valant, and Patrick M Sexton, and Arthur Christopoulos, and Christian C Felder, and Peter Gmeiner, and Jan Steyaert, and William I Weis, and K Christopher Garcia, and Jürgen Wess, and Brian K Kobilka
September 2009, Proceedings of the National Academy of Sciences of the United States of America,
Andrew C Kruse, and Aaron M Ring, and Aashish Manglik, and Jianxin Hu, and Kelly Hu, and Katrin Eitel, and Harald Hübner, and Els Pardon, and Celine Valant, and Patrick M Sexton, and Arthur Christopoulos, and Christian C Felder, and Peter Gmeiner, and Jan Steyaert, and William I Weis, and K Christopher Garcia, and Jürgen Wess, and Brian K Kobilka
March 2016, The Journal of biological chemistry,
Copied contents to your clipboard!